兰州肽库生物技术有限公司危险废物污染环境防治信息公示

In the rapidly evolving field of peptide therapeutics, identifying biologically active candidates—commonly referred to as “hits”—requires more than just large libraries of sequences. Structural diversity within a peptide library is a critical factor that directly influences the success of high-throughput screening and hit discovery.

Peptides play a central role in modern life sciences, serving as precision tools for target validation, mechanism-of-action studies, diagnostic reagent development, and early-stage drug discovery.

Scaling up peptide production is a critical step for researchers and pharmaceutical companies aiming to transition from laboratory experiments to larger-scale applications.